Medical Case Reports

Post-Covid-19 Vaccine Guillain-Barre Syndrome - A Case Report from Palestine

We present this case of a 50 year old gentleman with no previous history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 10 days after receiving the COVID-19 vaccination.

The diagnosis was based on physical examination, magnetic resonance imaging (MRI) of the spine, cerebrospinal fluid (CSF) analysis and electromyography (EMG).

The reported cases of GBS following vaccination supported the theory of molecular mimicry as an underlying pathophysiology for this disorder. However, research has not yet identified the exact mechanism at the molecular level. To the best of our knowledge this is the first case to be reported in Palestine. We hope that our report will encourage further research on this subject and will alarm healthcare professionals to put GBS in the differential diagnosis for patients who present with acute flaccid paralysis (AFP) after receiving the COVID-19 vaccine.

Author(s):

Hamdoon Abu-Arish Ahmed*

Abstract | Full-Text | PDF

Share this